Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers

PURPOSE: There is increasing evidence that neurodevelopmental differences in people with Fragile X syndrome (FraX) may be explained by differences in glutamatergic metabolism. Premutation carriers of FraX were originally considered to be unaffected although several recent reports demonstrate neuroan...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallahan, Brian P, Daly, Eileen M, Simmons, Andrew, Moore, Caroline J, Murphy, Kieran C, Murphy, Declan D G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443443/
https://www.ncbi.nlm.nih.gov/pubmed/22958351
http://dx.doi.org/10.1186/1866-1955-4-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443443/
https://www.ncbi.nlm.nih.gov/pubmed/22958351
http://dx.doi.org/10.1186/1866-1955-4-23

Ejemplares similares